GEHC: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/1d58903f-7db0-4fc0-bd05-60b0390d31c5/","filing_uuid":"1d58903f-7db0-4fc0-bd05-60b0390d31c5","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1d58903f-7db0-4fc0-bd05-60b0390d31c5/print/","filing_document_content_type":"text/html","income":null,"expenses":"350000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Betsy Tower","dt_posted":"2026-07-20T10:18:39-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 West Monroe Street","registrant_address_2":"c/o Nancy Rohrback","registrant_different_address":false,"registrant_city":"Chicago","registrant_state":"IL","registrant_zip":"60661","registrant":{"id":401107408,"url":"https://lda.gov/api/v1/registrants/401107408/","house_registrant_id":55993,"name":"GE HEALTHCARE TECHNOLOGIES INC.","description":null,"address_1":"500 West Monroe Street","address_2":"c/o Nancy Rohrback","address_3":null,"address_4":null,"city":"Chicago","state":"IL","state_display":"Illinois","zip":"60661","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BETSY TOWER","contact_telephone":"+1 202-297-3396","dt_updated":"2026-07-30T10:24:36.363712-04:00"},"client":{"id":54962,"url":"https://lda.gov/api/v1/clients/54962/","client_id":54962,"name":"GE HEALTHCARE TECHNOLOGIES INC.","general_description":"Global medical technology, pharmaceutical diagnostics and digital solutions company.","client_government_entity":null,"client_self_select":true,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-03-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues impacting artificial intelligence. Issues impacting corporate taxation. Issues impacting funding for health care including government research. Issues impacting health care and public health. Issues impacting manufacturing. Issues impacting medical device and health care cybersecurity. Issues impacting medical device regulation. Issues impacting medical insurance coverage. Issues impacting medical research. Issues impacting Medicare coverage and reimbursement for medical technology and health care services. Issues impacting radiopharmacetucials. Issues impacting servicing and repair of medical devices. Issues impacting wireless spectrum. Issues impacting international trade and supply chains. Issues impacting Veterans health. Issues related to insurance coverage for breast cancer screening. Issues related to maternal health. Issues related to critical minerals. S. 1866/H.R. 2381, SCREENS for Cancer Act of 2025, all provisions. S. 2339/H.R. 4541, EARLY Act Reauthorization of 2025, all provisions. S. 1591, ARCA Act of 2025, provisions related to healthcare. S. 1399/H.R. 6197, Health Tech Investment Act, all provisions. PL 119-21, An act to provide for reconciliation pursuant to title II of H.Con.Res. 14, implementation of provisions related to healthcare. S. 1410/H.R. 6182, Find It Early Act, all provisions. S. 1500/H.R. 3037 Access to Breast Cancer Diagnosis Act, all provisions. S. 2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 4121, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. S. 2256, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026, provisions related to healthcare. H.R. 8800/S. 4784, National Defense Authorization Act for Fiscal Year 2027, provisions related to healthcare. H.R. 3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026, provisions related to healthcare.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141904,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"FROMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141905,"prefix":null,"prefix_display":null,"first_name":"BETSY","nickname":null,"middle_name":null,"last_name":"TOWER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141906,"prefix":null,"prefix_display":null,"first_name":"MARCELLA","nickname":null,"middle_name":null,"last_name":"ORRIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}